https://www.socictopen.socict.org/files/original/96f8025ac288062c090df1e99a3db5c1.pdf 9a960c10fe8e09571e643db745b73245 Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus disease (COVID-19) and disseminated intravascular coagulation syndrome Creator An entity primarily responsible for making the resource A. S. Shkoda, A. D. Makatsariya, V. O. Bitsadze, J. Kh. Khizroeva, K. N. Grigoreva, M. A. Mingalimov, M. V. Tretyakova, I. Elalamy, V. B. Nemirovskiy, D. V. Blinov, D. V. Mitryuk Description An account of the resource COVID-19 is an infectious disease caused by the beta-coronavirus SARS-CoV-2 that in 2020 has spread worldwide. In most severe patients, the clinical picture begins with respiratory failure further deteriorating up to multiple organ failure. Development of coagulopathy is the most adverse prognostic. Analyzing currently available clinical data revealed that 71.4 % and 0.6 % of survivors and fatal cases, respectively, demonstrated signs of overt disseminated intravascular coagulation (DIC). Monitoring D-dimer level, prothrombin time, platelet count and fibrinogen content is important for determining indications for treatment and hospitalization in COVID-19 patients. In case such parameters deteriorate, a more pro-active “aggressive” intensive care should be applied. Low molecular weight heparin (LMWH) should be administered to all patients with diagnosed COVID-19 infection (including non-critical patients) requiring hospitalization, but having no contraindications to LMWH. Date A point or period of time associated with an event in the lifecycle of the resource 2020 Subject The topic of the resource coronavirus, covid-19, SARS-CoV-2, disseminated intravascular coagulation, low molecular weight heparin, DIC, anticoagulant therapy, LMWH Identifier An unambiguous reference to the resource within a given context 10.17749/2313-7347.132 Source A related resource from which the described resource is derived Акушерство, гинекология и репродукция Publisher An entity responsible for making the resource available IRBIS LLC Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Gynecology and obstetrics